ClassID:

94759

C07D277/34 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Oxygen atoms

Recent Application in this class:
#1
20260015327
2026-01-15

ACYLSULFONAMIDE KAT6A INHIBITORS

#2
20250374926
2025-12-11

NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE IN CROP PROTECTION

#3
20250320186
2025-10-16

HSD17B13 INHIBITORS AND USES THEREOF

#4
20250188039
2025-06-12

HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS

#5
20250136553
2025-05-01

ACYLSULFONAMIDE KAT6A INHIBITORS

#6
20250115564
2025-04-10

cGAS ANTAGONIST COMPOUNDS

#7
20250109105
2025-04-03

COMPOSITIONS AND METHODS FOR MAKING AND USING SMALL MOLECULES IN THE TREATMENT OF CANCER

#8
20250025443
2025-01-23

COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES

#9
20240336634
2024-10-10

AGONISTS OF TYRO3 AS PROTECTION AGAINST PODOCYTE INJURY IN KIDNEY GLOMERULAR DISEASE

#10
20240199535
2024-06-20

DEUTERATED DHODH INHIBITORS

#11
20240043393
2024-02-08

cGAS antagonist compounds

#12
20230416168
2023-12-28

N-HETEROCYCLIC COMPOUNDS USED AS NITRIFICATION INHIBITOR

#13
20230322692
2023-10-12

COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF

#14
20230126280
2023-04-27

Hydantoin containing deoxyuridine triphosphatase inhibitors

#15
20230123440
2023-04-20

MOSQUITO VECTOR CONTROL COMPOSITIONS, METHODS AND PRODUCTS UTILIZING SAME

#16
20230121086
2023-04-20

RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF

#17
20220402879
2022-12-22

Hydantoin containing deoxyuridine triphosphatase inhibitors

#18
20220362220
2022-11-17

5-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

#19
20220356158
2022-11-10

CGAS antagonist compounds

#20
20220324807
2022-10-13

Aromatic sulfonamide derivatives

#21
20220267286
2022-08-25

2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof

#22
20220211682
2022-07-07

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#23
20220135574
2022-05-05

BIARYL DERIVATIVE AS GPR120 AGONIST

#24
20220081432
2022-03-17

Prostaglandin E synthase inhibitors and methods for utilizing the same

#25
20220081390
2022-03-17

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

#26
20220047540
2022-02-17

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

#27
20220041566
2022-02-10

2-THIOXOTHIAZOLIDIN-4-ONE DERIVATIVES ACTIVE AS TRANSTHYRETIN LIGANDS AND USES THEREOF

#28
20210238139
2021-08-05

MODULATORS OF TRYPTOPHAN CATABOLISM

#29
20210032195
2021-02-04

Farnesoid X receptor agonists and uses thereof

#30
20200352898
2020-11-12

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

#31
20200331868
2020-10-22

Compound as PPAR agonist and application thereof

#32
20200315175
2020-10-08

Vector control compositions, methods and products utilizing same

#33
20200290975
2020-09-17

Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof

#34
20200277267
2020-09-03

METHODS FOR TREATING VASCULAR LEAK SYNDROME

#35
20200270207
2020-08-27

Deoxyuridine triphosphatase inhibitors

#36
20200255385
2020-08-13

Hydantoin containing deoxyuridine triphosphatase inhibitors

#37
20200253937
2020-08-13

5-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

#38
20200239457
2020-07-30

5-DEUTERO-THIAZOLIDINYLDIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

#39
20200231583
2020-07-23

Prostaglandin E synthase inhibitors and methods for utilizing the same

#40
20200207730
2020-07-02

METHODS FOR TREATING VASCULAR LEAK SYNDROME

#41
20200205406
2020-07-02

MICROBIOCIDAL PHENYLAMIDINE DERIVATIVES WITH IMPROVED PLANT SAFETY PROPERTIES

#42
20200148704
2020-05-14

HISTONE DEACETYLASE INHIBITORS

#43
20200148634
2020-05-14

ACLY inhibitors and uses thereof

#44
20200131142
2020-04-30

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

#45
20200009103
2020-01-09

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

#46
20200000788
2020-01-02

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#47
20190270719
2019-09-05

Deoxyuridine triphosphatase inhibitors

#48
20190119241
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

#49
20190119210
2019-04-25

Aromatic sulfonamide derivatives

#50
20190106395
2019-04-11

2-aryl-4-hydroxy-1,3-thiazole derivatives useful as TRPM8-inhibitors in treatment of neuralgia, pain, COPD and asthma

#51
20190092737
2019-03-28

2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof

#52
20190082687
2019-03-21

Mosquito vector control compositions, methods and products utilizing same

#53
20190029990
2019-01-31

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

#54
20190016695
2019-01-17

Thiazolidinedione derivative and use thereof

#55
20180346416
2018-12-06

N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

#56
20180334431
2018-11-22

Deoxyuridine triphosphatase inhibitors

#57
20180327423
2018-11-15

Histone deacetylase inhibitors

#58
20180282263
2018-10-04

Farnesoid X receptor agonists and uses thereof

#59
20180265524
2018-09-20

SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS

#60
20180230115
2018-08-16

cGAS antagonist compounds

#61
20180208606
2018-07-26

Histone deacetylase inhibitors

#62
20180208589
2018-07-26

LMP7 inhibitors

#63
20180194736
2018-07-12

Hydantoin containing deoxyuridine triphosphatase inhibitors

#64
20180194732
2018-07-12

Multi-API loading prodrugs

#65
20180186737
2018-07-05

Hydantoin containing deoxyuridine triphosphatase inhibitors

#66
20180155319
2018-06-07

Deoxyuridine triphosphatase inhibitors

#67
20180133204
2018-05-17

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#68
20180125827
2018-05-10

5-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

#69
20180118730
2018-05-03

5-DEUTERO-THIAZOLIDINYLDIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

#70
20180079723
2018-03-22

Monocyclic compound

#71
20180016245
2018-01-18

METHODS FOR TREATING VASCULAR LEAK SYNDROME

#72
20170349594
2017-12-07

Biaryl derivative as GPR120 agonist

#73
20170298020
2017-10-19

METHODS AND COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS AND VIRAL INFECTIONS

#74
20170291893
2017-10-12

PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITORS AND METHODS OF USE THEREOF

#75
20170217959
2017-08-03

Neprilysin inhibitors

#76
20170190678
2017-07-06

2-aryl-4-hydroxy-1,3-thiazole derivatives useful as TRPM8-inhibitors in treatment of neuralgia, pain, COPD and asthma

#77
20170049762
2017-02-23

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#78
20170044186
2017-02-16

Histone deacetylase inhibitors

#79
20160257641
2016-09-08

Alkylene derivatives

#80
20160244417
2016-08-25

Cathepsin cysteine protease inhibitors

#81
20160229796
2016-08-11

Metformin salts to treat Type2 diabetes

#82
20160168116
2016-06-16

IRE-1α inhibitors

#83
20160159758
2016-06-09

3-(2-amino-ethyl)-alkylidene)-thiazolidine-2,4-dione and 1-(2-amino-ethyl)-alkylidene-1,3-dihydro-indol-2-one derivatives as selective sphingosine kinase 2 inhibitors

#84
20160102065
2016-04-14

Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof

#85
20160102051
2016-04-14

Methods and compounds for treating proliferative disorders and viral infections

#86
20160051521
2016-02-25

Thiazolidinediones of omega-3 polyunsaturated acids as new insulin sensitizers for treating type2 diabetes

#87
20160039788
2016-02-11

Deoxyuridine triphosphatase inhibitors

#88
20160016900
2016-01-21

Thromboxane receptor antagonists

#89
20150361075
2015-12-17

Compounds that modulate intracellular calcium

#90
20150336916
2015-11-26

Epoxyeicosatrienoic acid analogs and methods of making and using the same

#91
20150322002
2015-11-12

N-substituted benzamides and methods of use thereof

#92
20150315211
2015-11-05

Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders

#93
20150315178
2015-11-05

Plasminogen activator inhibitor-1 inhibitors and methods of use thereof

#94
20150284346
2015-10-08

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#95
20150246938
2015-09-03

NOVEL OLEFIN DERIVATIVE

#96
20150218124
2015-08-06

Catechol O-methyltransferase activity inhibiting compounds

#97
20150181878
2015-07-02

Active compound combinations

#98
20150158884
2015-06-11

Histone deacetylase inhibitors

#99
20150139908
2015-05-21

Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method

#100
20150111891
2015-04-23

Naphthalene acetic acid derivatives against HIV infection

#101
20150051406
2015-02-19

PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

#102
20150051255
2015-02-19

Glucose transporter inhibitors

#103
20150031733
2015-01-29

Tetrazolinone compounds and its use

#104
20150005353
2015-01-01

3-(2-AMINO-ETHYL)-ALKYLIDENE)-THIAZOLIDINE-2,4-DIONE AND 1-(2-AMINO-ETHYL)-ALKYLIDENE-1,3-DIHYDRO-INDOL-2-ONE DERIVATIVES AS SELECTIVE SPHINGOSINE KINASE 2 INHIBITORS

#105
20140364465
2014-12-11

Thiazolidinedione derivatives, preparation thereof and use thereof in cancer treatment

#106
20140364461
2014-12-11

METHOD OF TREATING DERMATOLOGICAL DISORDERS

#107
20140323518
2014-10-30

Estrogen receptor ligands

#108
20140288106
2014-09-25

Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists

#109
20140275529
2014-09-18

Subunit selective NMDA receptor potentiators for the treatment of neurological conditions

#110
20140275180
2014-09-18

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#111
20140275088
2014-09-18

Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors

#112
20140243366
2014-08-28

Compounds that modulate intracellular calcium

#113
20140179743
2014-06-26

Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK)

#114
20140155597
2014-06-05

Amidine compound or salt thereof

#115
20140142120
2014-05-22

Method of treating cancer with modulators of SCFSkp2

#116
20140113884
2014-04-24

Epoxyeicosatrienoic acid analogs and methods of making and using the same

#117
20140107153
2014-04-17

THERAPEUTIC QUINOLINE AND NAPHTHALENE DERIVATIVES

#118
20140080832
2014-03-20

IRE-1α inhibitors

#119
20140066458
2014-03-06

METHODS FOR TREATING VASCULAR LEAK SYNDROME

#120
20140038970
2014-02-06

Bridged and fused antidiabetic compounds

#121
20140023603
2014-01-23

Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor

#122
20130345268
2013-12-26

Methods and Compositions for the Treatment of RAS Associated Disorders

#123
20130317003
2013-11-28

Histone deacetylase inhibitors

#124
20130316906
2013-11-28

Phenyl-substituted bicyclooctane-1,3-dione-derivatives

#125
20130281414
2013-10-24

THIAZOLIDINEDIONE ANALOGUES

#126
20130253021
2013-09-26

Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors

#127
20130225596
2013-08-29

Heterocyclic derivative and pharmaceutical composition comprising the same

#128
20130204008
2013-08-08

Synthesis for thiazolidinedione compounds

#129
20130204004
2013-08-08

Synthesis for thiazolidinedione compounds

#130
20130109710
2013-05-02

SPIRO COMPOUNDS AND PHARMACEUTICAL USE THEREOF

#131
20130079346
2013-03-28

Benzoic acid derivatives

#132
20130035304
2013-02-07

SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS

#133
20120309975
2012-12-06

PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

#134
20120238759
2012-09-20

METHOD FOR MANUFACTURING A 6-SUBSTITUTED 1-METHYL-1H-BENZIMIDAZOLE DERIVATIVE AND AN INTERMEDIATE OF SAID METHOD

#135
20120202823
2012-08-09

Multi-API Loading Prodrugs

#136
20120196838
2012-08-02

COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES

#137
20120157386
2012-06-21

Neprilysin inhibitors

#138
20120149710
2012-06-14

SORTASE A INHIBITORS

#139
20120108571
2012-05-03

Substituted phenoxy N-alkylated thiazolidinediones as estrogen related receptor-α modulators

#140
20120028977
2012-02-02

Subunit selective NMDA receptor potentiators for the treatment of neurological conditions

#141
20120028804
2012-02-02

3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide

#142
20110319416
2011-12-29

Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions

#143
20110313008
2011-12-22

PENTAFLUOROSULPHOLANE-CONTAINING ANTIDIABETIC COMPOUNDS

#144
20110312967
2011-12-22

BRIDGED AND FUSED ANTIDIABETIC COMPOUNDS

#145
20110281921
2011-11-17

Anti-biofilm agents

#146
20110269954
2011-11-03

Thiazolidinedione derivative and use thereof

#147
20110269763
2011-11-03

CRTH2 receptor ligands for medicinal uses

#148
20110268694
2011-11-03

METHODS FOR TREATING VASCULAR LEAK SYNDROME

#149
20110263664
2011-10-27

Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer

#150
20110237625
2011-09-29

Substituted phenoxy thiazolidinediones as estrogen related receptor-á modulators

#151
20110236310
2011-09-29

LABELING COMPOSITION FOR INTRAOCULAR TISSUE, LABELING METHOD OF INTRAOCULAR TISSUE, AND SCREENING METHOD

#152
20110218182
2011-09-08

Chemical compounds 251

#153
20110166191
2011-07-07

3-(2-amino-ethyl)-5-(3-cyclohexyl-propylidene)-thiazolidine-2,4-dione and its derivatives as multiple signaling pathway inhibitors and for the treatment of cancer

#154
20110092555
2011-04-21

Thiazolidinedione compound

#155
20110065162
2011-03-17

IRE-1α inhibitors

#156
20110046177
2011-02-24

Therapeutic quinoline and naphthalene derivatives

#157
20110034450
2011-02-10

Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof

#158
20100305164
2010-12-02

5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases

#159
20100298388
2010-11-25

Substituted benzamidines as antibacterial agents

#160
20100273836
2010-10-28

Oxime ether derivative and fungicide for agricultural and horticultural use

#161
20100249077
2010-09-30

Pyridylmethyl-sulfonamide compounds

#162
20100234612
2010-09-16

Intermediate of 6-substituted-1-methyl-1-H-benzimidazole derivative and method for producing same

#163
20100222399
2010-09-02

Thiazolidinedione analogues for the treatment of metabolic diseases

#164
20100222326
2010-09-02

New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders

#165
20100210524
2010-08-19

NOVEL ESTROGEN RECEPTOR LIGANDS

#166
20100204472
2010-08-12

Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation

#167
20100173778
2010-07-08

3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide

#168
20100168184
2010-07-01

Small molecule Bcl-Xl/Bcl-2 binding inhibitors

#169
20100160302
2010-06-24

Dipeptidyl peptidase IV inhibitors and processes for their preparation and pharmaceutical compositions containing them

#170
20100143563
2010-06-10

FLAVOURING A FOODSTUFF BY INCORPORATING AN EFFECTIVE AMOUNT OF AT LEAST ONE COMPOUND OF THE FORMULA R1-S-R2 IN WHICH R1 AND R2 REPRESENT A SPECIFIC ATOM OR GROUP

#171
20100130572
2010-05-27

Cytoskeletal active compounds, composition and use

#172
20100130522
2010-05-27

COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES

#173
20100113276
2010-05-06

USE OF N2-PHENYLAMIDINES AS HERBICIDES

#174
20100048590
2010-02-25

N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS

#175
20100009991
2010-01-14

Polycyclic acid compounds useful as CRTH2 antagonists and antiallergic agents

#176
20090312376
2009-12-17

5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases

#177
20090312303
2009-12-17

Antidiabetic bicyclic compounds

#178
20090306110
2009-12-10

N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor

#179
20090291992
2009-11-26

Androgen receptor-ablative agents

#180
20090258914
2009-10-15

Inhibitor of Anti-Apoptotic Proteins

#181
20090227604
2009-09-10

Vitamin D receptor modulators

#182
20090215758
2009-08-27

Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs

#183
20090209598
2009-08-20

Resorcine Derivatives and Their Use as Pesticides

#184
20090197870
2009-08-06

Benzylthiazolone inhibitors of estrogen-related receptors (ERR)

#185
20090186893
2009-07-23

IRE-1α inhibitors

#186
20090176837
2009-07-09

COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS

#187
20090170908
2009-07-02

Spiro compounds and pharmaceutical use thereof

#188
20090149425
2009-06-11

Malononitrile compound as pesticides

#189
20090143446
2009-06-04

THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF

#190
20090111855
2009-04-30

Substituted phenoxy thiazolidinediones as estrogen related receptor-α modulators

#191
20090105257
2009-04-23

Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40

#192
20090099189
2009-04-16

CRTH2 receptor ligands for medicinal uses

#193
20090088457
2009-04-02

Primary Amines as Renin Inhibitors

#194
20090075819
2009-03-19

Indanyl- and tetrahydronaphtyl-amino-thiourea compounds for combating animal pests

#195
20090069313
2009-03-12

Novel MAO-A inhibitors

#196
20090042909
2009-02-12

Method of treating dermatological disorders

#197
20090023929
2009-01-22

Intermediate of 6-substituted 1-methyl-1-H-benzimidazole derivative and method for producing same

#198
20090018058
2009-01-15

Vitamin D receptor modulators

#199
20080293949
2008-11-27

Heterocyclic analogs of diphenylethylene compounds

#200
20080286265
2008-11-20

Substituted phenoxy N-alkylated thiazolidinediones as estrogen related receptor-α modulators

#201
20080255196
2008-10-16

Pesticide thiazolyloxy substituted phenylamidine derivatives

#202
20080233163
2008-09-25

Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof

#203
20080221179
2008-09-11

Substituted phenoxy aminothiazolones as estrogen related receptor-α modulators

#204
20080200470
2008-08-21

Diaza- or Thiazadione Derivatives With Neuroprotective Activity

#205
20080167378
2008-07-10

Receptor function regulating agent

#206
20080161368
2008-07-03

Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome

#207
20080103185
2008-05-01

Process for Producing Thiazolidinedione Compound and Production Intermediate Thereof

#208
20080076735
2008-03-27

Cytoskeletal active compounds, composition and use

#209
20080058333
2008-03-06

CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS

#210
20070225332
2007-09-27

Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome

#211
20070219251
2007-09-20

Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome

#212
20070203188
2007-08-30

Low molecular weight Myc-max inhibitors

#213
20070197523
2007-08-23

CALCIUM CHANNEL ANTAGONISTS

#214
20070173434
2007-07-26

Antidiabetic oxazolidinediones and thiazolidinediones

#215
20070155807
2007-07-05

Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents

#216
20070155748
2007-07-05

N-sulfonyl-α-amino-acid derivatives

#217
20070105846
2007-05-10

Phenylene derivative having tetrazole ring or thiazolidinedione ring

#218
20070099969
2007-05-03

Design and synthesis of optimized ligands for PPAR

#219
20070099909
2007-05-03

N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR

#220
20070054900
2007-03-08

4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy

#221
20070043046
2007-02-22

Biaromatic ligand activators of PPARγ receptors

#222
20070021382
2007-01-25

Nitric oxide donors and uses thereof

#223
20070010566
2007-01-11

Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents

#224
20070010565
2007-01-11

New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents

#225
20060252803
2006-11-09

Hydrogenation of precursors to thiazolidinedione antihyperglycemics

#226
20060252802
2006-11-09

Small molecule cyclin D1 ablative agents

#227
20060252801
2006-11-09

Small molecule Bcl-xL/Bcl-2 binding inhibitors

#228
20060247285
2006-11-02

Heterocyclic diphenyl ethers

#229
20060235062
2006-10-19

Novel heterocyclic analogs of diphenylethylene compounds

#230
20060217427
2006-09-28

Cytoskeletal active compounds, compositions and use

#231
20060194817
2006-08-31

N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds

#232
20060183918
2006-08-17

β2-adrenergic receptor agonists

#233
20060183913
2006-08-17

Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof

#234
20060183805
2006-08-17

Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof

#235
20060183718
2006-08-17

Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof

#236
20060166987
2006-07-27

Opioid receptor antagonists

#237
20060149075
2006-07-06

Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione

#238
20060142303
2006-06-29

Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents

#239
20060084680
2006-04-20

Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation

#240
20060084657
2006-04-20

Piperazine derivative

#241
20060079503
2006-04-13

Thiazolidinones and the use therof as polo-like kinase inhibitors

#242
20060069138
2006-03-30

Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof

#243
20060069137
2006-03-30

Process for ezetimibe intermediate

#244
20060063820
2006-03-23

2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties

#245
20060040998
2006-02-23

Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof

#246
20060014800
2006-01-19

Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders

#247
20060014781
2006-01-19

Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging

#248
20060009511
2006-01-12

N-(2-Arylethyl) benzylamines as antagonists of the 5-HTreceptor

#249
20060004059
2006-01-05

Substituted heterocycles for the treatment of diabetes and other diseases

#250
20050288341
2005-12-29

Diphenyl ether derivatives

#251
20050277678
2005-12-15

Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine

#252
20050250777
2005-11-10

Cycloalkanedione derivatives, method for the production thereof and their pharmacological applications

#253
20050234125
2005-10-20

Alpha-sulfonylamino-acetonitriles

#254
20050209275
2005-09-22

β2-adrenergic receptor agonists

#255
20050187258
2005-08-25

Hydrogenation of precursors to thiazolidinedione antihyperglycemics

#256
20050165072
2005-07-28

Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers

#257
20050137238
2005-06-23

Biaromatic ligand activators of PPARγ receptors

#258
20050096366
2005-05-05

Amino acid phenoxy ethers

#259
20050090400
2005-04-28

3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide

#260
20050085541
2005-04-21

Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof

#261
20050075379
2005-04-07

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

#262
20050075345
2005-04-07

Novel inhibitor compounds specific of secreted non-pancreatic human a2phospholipase of group II

#263
20050070581
2005-03-31

Imidazolidinedione derivatives for the treatment of diabetes and other diseases

#264
20050065197
2005-03-24

Thiazole derivatives with fungicidal activity

#265
20050065066
2005-03-24

Stabilised insulin compositions

#266
20050054819
2005-03-10

Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors

#267
20050038259
2005-02-17

Hydroxyeicosenoic acid anaglogs

#268
20050038098
2005-02-17

Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases

#269
20050038087
2005-02-17

Derivatives of heterocycles with 5 members, their preparation and their use as medicaments

#270
20050037997
2005-02-17

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

#271
20050032864
2005-02-10

Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases

#272
20050020680
2005-01-27

Hydroxyfattysulfonic acid analogs

#273
19052060
2025-07-08

Method of heavy metal ion detection using chemosensors

#274
18590133
2024-06-04

Thiazole tethered organoselenides as 5-lipoxygenase inhibitors

#275
16510198
2020-06-23

Pyrimidine-thiazolidinone derivatives